Changing paradigms in intermediate-risk cervical cancer: Sedlis revisited

Gynecol Oncol. 2021 Sep;162(3):527-528. doi: 10.1016/j.ygyno.2021.08.004.

Authors

Puja Venkat¹, Ritu Salani²

Affiliations

¹ Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, United States of America.
² Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, United States of America. Electronic address: rsalani@mednet.ucla.edu.

PMID: 34454679
DOI: 10.1016/j.ygyno.2021.08.004

No abstract available

Publication types

Editorial
Comment

MeSH terms

Female
Humans
Hysterectomy
Neoplasm Staging
Uterine Cervical Neoplasms* / pathology